- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- July 2023
- 129 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- March 2019
- 16 Pages
Global
€9101EUR$10,000USD£7,802GBP
- Report
- March 2024
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Book
- February 2024
- 592 Pages
Citalopram is an antidepressant drug used to treat mental disorders such as depression, anxiety, and panic disorder. It is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the amount of serotonin in the brain. Citalopram is available in both generic and brand-name forms. It is typically taken once daily, with or without food. Common side effects include nausea, headache, and insomnia.
Citalopram is one of the most commonly prescribed drugs for mental disorders. It is used to treat a wide range of conditions, including depression, anxiety, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. It is also used to treat premenstrual dysphoric disorder and hot flashes associated with menopause.
The citalopram market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Mylan. Other companies include Teva Pharmaceuticals, Sun Pharmaceuticals, and Sandoz. Show Less Read more